Joseph Choi

Joseph Choi is a health care reporter for The Hill. He covers policy and politics related to the sector. He has previously reported on topics such as diabetes drugs, COVID-19 vaccines, and mental health issues. Choi joined The Hill in 2020 after working as an editorial assistant at Roll Call, a newspaper that covers Congress. He graduated from American University with a degree in journalism and sociology. He is also interested in social justice issues and has volunteered for several nonprofits focused on education, housing, and immigration.

95%

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

  • The author tends to report on studies and research that support the pharmaceutical industry's interests.

Conflicts of Interest

100%

Examples:

  • ],

Contradictions

50%

Examples:

No current examples available.

Deceptions

85%

Examples:

No current examples available.

Recent Articles

Novo Nordisk's Diabetes and Weight Loss Drugs: $600 a Month in the US, $59 in Germany - CEO to Testify Before Senate Committee

Novo Nordisk's Diabetes and Weight Loss Drugs: $600 a Month in the US, $59 in Germany - CEO to Testify Before Senate Committee

Broke On: Monday, 17 June 2024 Novo Nordisk, Europe's most valuable company in 2023, faces scrutiny over price discrepancies of diabetes drugs Ozempic and Wegovy in the US. The CEO will testify before the Senate HELP committee regarding these high prices, which are significantly lower in other countries. A study found that Ozempic costs $541 less per month in Germany, while Wegovy costs $727 less in the UK. Critics argue that justifications for these price disparities do not excuse such significant differences.
Dr. Fauci's Career Milestones and Recent Controversies: A Factual Account

Dr. Fauci's Career Milestones and Recent Controversies: A Factual Account

Broke On: Monday, 03 June 2024 Dr. Anthony S. Fauci, a 50-year NIH veteran and NIAID director, led groundbreaking HIV research, mRNA technology development, and pandemic flu research. His tenure saw billions invested in mRNA tech that paved the way for COVID-19 vaccines. Amidst political scrutiny during the pandemic, Fauci denied wrongdoing regarding FOIA requests and refuted allegations of downplaying lab-leak theories.
Dramatic Increase in Seizures of Illicit Fentanyl Pills in the US: A Shifting Drug Landscape

Dramatic Increase in Seizures of Illicit Fentanyl Pills in the US: A Shifting Drug Landscape

Broke On: Monday, 13 May 2024 From 2017 to 2023, illicit fentanyl pill seizures in the US surged, with over 115 million pills seized in the latter year. This represents a quadrupling of pill seizures to total fentanyl seizures and a major shift in the drug landscape. Fentanyl pills are particularly dangerous due to their potency, with lethal doses as small as two milligrams. The Western US, specifically California, Arizona, and Florida, has seen the most significant increase in pill seizures.
Arizona House Takes Step to Repeal Century-Old Abortion Ban: A Look at the Vote and Implications

Arizona House Takes Step to Repeal Century-Old Abortion Ban: A Look at the Vote and Implications

Broke On: Wednesday, 24 April 2024 The Arizona House votes to repeal a century-old abortion ban, a crucial step for women's reproductive freedom and healthcare access. The 1864 law prohibited all abortions except those necessary to save a woman's life and carried a prison sentence for providers. Democrats gather signatures for a constitutional amendment proposal, while Republicans oppose the repeal. Governor Katie Hobbs is expected to sign the repeal if it reaches her desk.
New FDA Approval for Wegovy: Potential Medicare Coverage and Implications for Cardiovascular Disease Patients with Obesity

New FDA Approval for Wegovy: Potential Medicare Coverage and Implications for Cardiovascular Disease Patients with Obesity

Broke On: Wednesday, 24 April 2024 The FDA's approval of Wegovy for reducing cardiovascular risks in obese patients with CVD opens up potential Medicare coverage, affecting 3.6 million beneficiaries. However, current laws prohibit Medicare from covering weight loss medications, and costs could reach an additional $2.8 billion annually if just 10% of eligible beneficiaries use it.
New Monkeypox Variant May Lead to Faster Rise in Cases and Increased Risk of Death

New Monkeypox Variant May Lead to Faster Rise in Cases and Increased Risk of Death

Broke On: Thursday, 04 April 2024 A new variant of the monkeypox virus may lead to a faster rise in cases due to its subtype causing more severe symptoms and potentially spreading easily. The CDC warns that this new strain increases the risk of contracting monkeypox, which can be fatal.
Wegovy Now Covered Under Medicare Part D for Heart Health in Obese and Overweight Adults

Wegovy Now Covered Under Medicare Part D for Heart Health in Obese and Overweight Adults

Broke On: Thursday, 21 March 2024 Medicare Part D covers Wegovy, a weight loss drug that reduces heart risks for obese or overweight adults. The FDA approved it in March after a clinical trial showed 20% reduction in serious heart events.
Record-Breaking Drug Overdose Deaths in 2022: Fentanyl Takes the Blame

Record-Breaking Drug Overdose Deaths in 2022: Fentanyl Takes the Blame

Broke On: Thursday, 21 March 2024 In 2022, a record-breaking number of Americans died from drug overdoses, with fentanyl being the primary cause.
RSV Monoclonal Antibody Products Show 90% Effectiveness in Preventing Hospitalization for Children and Infants During RSV Season

RSV Monoclonal Antibody Products Show 90% Effectiveness in Preventing Hospitalization for Children and Infants During RSV Season

Broke On: Friday, 08 March 2024 A new study shows that two monoclonal antibody treatments, Beyfortus and nirsevimab, can effectively prevent RSV hospitalization in infants. These treatments are given as a single dose at the first sign of symptoms or before exposure to high-risk settings. Parents should be aware of the signs of RSV and seek medical help if their child has difficulty breathing or bluish skin.
Alabama Supreme Court Rules Frozen Embryos Children Under State Law, Subject to Wrongful Death Legislation

Alabama Supreme Court Rules Frozen Embryos Children Under State Law, Subject to Wrongful Death Legislation

Broke On: Monday, 19 February 2024 The Alabama Supreme Court has ruled that frozen embryos are children under state law and subject to legislation dealing with the wrongful death of minor. The court issued this majority decision in a lawsuit brought forth by a group of IVF patients whose frozen embryos were destroyed in December 2020 when a patient removed the embryos from a cryogenic storage unit and dropped them on the ground. The plaintiffs subsequently filed two lawsuits against the facility, alleging that it had violated Alabama's Wrongful Death of a Minor Act, which applies to unborn children.